LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

ZACKS INVESTMENT MANAGEMENT's Holding History (CIK: 0001086483)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 14,127 Value ($000) $32 Avg Close — Range —
Q1 2023
Shares 10,831 Value ($000) $26 Avg Close — Range —
Q4 2022
Shares 10,831 Value ($000) $38 Avg Close — Range —